Search results
Nov 9, 2020 · Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis Analysis evaluated 94 confirmed cases of COVID-19 in trial participants Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and ...
- Overview
- Why get vaccinated?
- COVID-19 vaccine
- What if there is a serious problem?
- Countermeasures Injury Compensation Program
- How can I learn more?
On This Page
•Why get vaccinated?
•COVID-19 vaccine
•Talk with your health care provider
•Risks of a vaccine reaction
•What if there is a serious problem?
COVID-19 vaccine can prevent COVID-19 disease. Vaccination can help reduce the severity of COVID-19 disease if you get sick.
COVID-19 is caused by a coronavirus called SARS-CoV-2 that spreads easily from person to person. COVID-19 can cause mild to moderate illness lasting only a few days, or severe illness requiring hospitalization, intensive care, or a ventilator to help with breathing. COVID-19 can result in death.
If an infected person has symptoms, they may appear 2 to 14 days after exposure to the virus. Anyone can have mild to severe symptoms.
•Possible symptoms include fever or chills, cough, shortness of breath or difficulty breathing, fatigue (tiredness), muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea.
•More serious symptoms can include trouble breathing, persistent pain or pressure in the chest, new confusion, inability to wake or stay awake, or pale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone.
Older adults and people with certain underlying medical conditions (like heart or lung disease or diabetes) are more likely to get very sick from COVID-19.
Updated (2023–2024 Formula) COVID-19 vaccine is recommended for everyone 6 months of age and older.
COVID-19 vaccines for infants and children 6 months through 11 years of age are available under Emergency Use Authorization from the U. S. Food and Drug Administration (FDA). Please refer to the Fact Sheets for Recipients and Caregivers for more information.
For people 12 years of age and older, updated COVID-19 vaccines, manufactured by ModernaTX, Inc. or Pfizer, Inc., are approved by FDA.
•Everyone 12 years and older should get 1 dose of an FDA-approved, updated 2023–2024 COVID-19 vaccine. If you have received a COVID-19 vaccine recently, you should wait at least 8 weeks after your most recent dose to get the updated 2023–2024 COVID-19 vaccine.
•Certain people who have medical conditions or are taking medications that affect the immune system may get additional doses of COVID-19 vaccine. Your health care provider can advise you.
Some people 12 years of age and older might get a different COVID-19 vaccine called Novavax COVID-19 Vaccine, Adjuvanted (2023–2024 Formula) instead. This vaccine is available under Emergency Use Authorization from FDA. Please refer to the Fact Sheet for Recipients and Caregivers for more information.
An allergic reaction could occur after the vaccinated person leaves the clinic. If you see signs of a severe allergic reaction (hives, swelling of the face and throat, difficulty breathing, a fast heartbeat, dizziness, or weakness), call 9-1-1 and get the person to the nearest hospital.
Seek medical attention right away if the vaccinated person experiences chest pain, shortness of breath, or feelings of having a fast-beating, fluttering, or pounding heart after COVID-19 vaccination. These could be symptoms of myocarditis or pericarditis.
For other signs that concern you, call your health care provider.
Adverse reactions should be reported to the Vaccine Adverse Event Reporting System (VAERS). Your health care provider will usually file this report, or you can do it yourself. Visit the VAERS website or call 1-800-822-7967. VAERS is only for reporting reactions, and VAERS staff members do not give medical advice.
The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one (1) year from the date of receivin...
•Ask your health care provider.
•Call your local or state health department.
•Visit the website of the Food and Drug Administration (FDA) for COVID-19 Fact Sheets, package inserts, and additional information.
•Contact the Centers for Disease Control and Prevention (CDC):
•Call 1-800-232-4636 (1-800-CDC-INFO) or
•Visit CDC’s COVID-19 vaccines website
Aug 23, 2021 · THE PRESIDENT: Good afternoon. Today, we have hit another milestone — a key milestone — in our nation’s fight against COVID. The Food and Drug Administration, the FDA, announced that it’s ...
Aug 20, 2020 · In a Phase 1 study in the U.S., at 7 days after a second dose of 30μg, BNT162b2 elicited SARS-CoV-2–neutralizing geometric mean titers (GMTs) in younger adults (18-55 years of age) that were 3.8 times the GMT of a panel of 38 sera of SARS-CoV-2 convalescent patients, and in older adults (65-85 years of age) the vaccine candidate elicited a neutralizing GMT 1.6 times the GMT of the same ...
Coronavirus (COVID-19) HHS and our federal partners are working together with state, local, tribal and territorial governments, public health officials, health care providers, researchers, private sector organizations and the public to protect the health and safety of the American people. For COVID-19 resources for you and your loved ones ...
Dec 1, 2020 · Depending on the amount ordered, its vaccine candidate will cost between $25 (£19) and $37 (£28) per dose. The potential benefits of mRNA vaccines like Moderna's are great. They can be quicker ...
Aug 17, 2022 · Coronavirus and Covid-19 are not the same thing, but sometimes the terms can be used interchangeably. This “novel coronavirus” is novel because it just emerged in humans in late 2019.
